KCa3.1 Impairment Is Not Just a Slow Afterthought in Epilepsy

Overview

Journal Epilepsy Curr

Publisher Sage Publications

Date 2021 May 24

PMID 34025230

Citations 2

Authors

Christina Gross

Affiliations

Soon will be listed here.

Citing Articles

Imaging of K 3.1 Channels in Tumor Cells with PET and Small-Molecule Fluorescent Probes.

Thale I, Maskri S, Grey L, Todesca L, Budde T, Maisuls I ChemMedChem. 2022; 18(2):e202200551.

PMID: 36315933 PMC: 10098740. DOI: 10.1002/cmdc.202200551.

Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K3.1) channels .

Brommel K, Paul Konken C, Borgel F, Obeng-Darko H, Schelhaas S, Bulk E RSC Adv. 2022; 11(48):30295-30304.

PMID: 35480282 PMC: 9041111. DOI: 10.1039/d1ra03850h.

References

Tiwari M, Mohan S, Biala Y, Yaari Y . Protein Kinase A-Mediated Suppression of the Slow Afterhyperpolarizing KCa3.1 Current in Temporal Lobe Epilepsy. J Neurosci. 2019; 39(50):9914-9926. PMC: 6978949. DOI: 10.1523/JNEUROSCI.1603-19.2019. View

Bernard C, Anderson A, Becker A, Poolos N, Beck H, Johnston D . Acquired dendritic channelopathy in temporal lobe epilepsy. Science. 2004; 305(5683):532-5. DOI: 10.1126/science.1097065. View

Begenisich T, Nakamoto T, Ovitt C, Nehrke K, Brugnara C, Alper S . Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4. J Biol Chem. 2004; 279(46):47681-7. DOI: 10.1074/jbc.M409627200. View

Turner R, Asmara H, Engbers J, Miclat J, Rizwan A, Sahu G . Assessing the role of IKCa channels in generating the sAHP of CA1 hippocampal pyramidal cells. Channels (Austin). 2016; 10(4):313-9. PMC: 4954577. DOI: 10.1080/19336950.2016.1161988. View

Wang K, Mateos-Aparicio P, Honigsperger C, Raghuram V, Wu W, Ridder M . IK1 channels do not contribute to the slow afterhyperpolarization in pyramidal neurons. Elife. 2016; 5:e11206. PMC: 4733036. DOI: 10.7554/eLife.11206. View

Becker A . Review: Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis. Neuropathol Appl Neurobiol. 2017; 44(1):112-129. DOI: 10.1111/nan.12451. View

Snowball A, Chabrol E, Wykes R, Shekh-Ahmad T, Cornford J, Lieb A . Epilepsy Gene Therapy Using an Engineered Potassium Channel. J Neurosci. 2019; 39(16):3159-3169. PMC: 6468110. DOI: 10.1523/JNEUROSCI.1143-18.2019. View

Agarwal J, Zhu Y, Zhang Q, Mongin A, Hough L . TRAM-34, a putatively selective blocker of intermediate-conductance, calcium-activated potassium channels, inhibits cytochrome P450 activity. PLoS One. 2013; 8(5):e63028. PMC: 3646888. DOI: 10.1371/journal.pone.0063028. View

Wei T, Wang Y, Xu W, Liu Y, Chen H, Yu Z . KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway. Neurobiol Dis. 2019; 132:104588. DOI: 10.1016/j.nbd.2019.104588. View

10.

Ongerth T, Russmann V, Fischborn S, Boes K, Siegl C, Potschka H . Targeting of microglial KCa3.1 channels by TRAM-34 exacerbates hippocampal neurodegeneration and does not affect ictogenesis and epileptogenesis in chronic temporal lobe epilepsy models. Eur J Pharmacol. 2014; 740:72-80. DOI: 10.1016/j.ejphar.2014.06.061. View